According to the latest revised version of the Statistical Manual of Mental Disorders [1], which coincides with the DSM-5 [2], neurodevelopmental disorders (NDs) are those that include a clinical manifestation in almost all developmental domains. These manifestations include intellectual disability (ID), as well as those that affect more specific domains, such as attention-deficit/hyperactivity disorder (ADHD), autism spectrum disorder (ASD), communication disorders (CDs), specific learning disorders (SLDs, including difficulties in reading, writing and mathematics), and motor skill disorders (MDs, such as Tics, Tourette’s syndrome and stereotypic disorders), among others [3].
NDs usually begin in childhood, although most of them are chronic and persist for life. A new approach is committed to the inclusion of NDs within a heterogeneous and dimensional group, leaving behind the categorical classifications of the DSM-4th edition [4] and the International Statistical Classification of Diseases and Related Health Problems (ICD) [5]. The new edition of the ICD (ICD-11) unifies its criteria with those of the DSM-5 (2013). Finally, the revised DSM-5 (i.e., DSM-5-TR) was recently published in 2022.
To our knowledge, there are only a few studies in the scientific literature that measure the prevalence of NDs in minors according to DSM-5 criteria (2013). The prevalence rates reported in 2022 were as follows: ID, 0.63%; ADHD, 5–11%; ASD, 0.70–3%; SLDs, 3–10%; CDs, 1–3.42%; and MDs, 0.76–17% [3, 6,7,8,9,10,11].
Among the available literature, prevalence studies and meta-analyses are the most common. The prevalence rates of the most common NDs were estimated as follows: ADHD, 7.9–9.5% [12, 13]; SLDs, 0.7–2.2% [12, 14, 15]; SLDs (including developmental dyslexia [DD]), 1.2–24% [16, 17]; and MDs, 1.4–19% [18, 19]. Furthermore, reported prevalence rates for various disorders within the same study did not include comorbidity rates between disorders [10].
In the United States, according to data published by the National Center for Health Statistics (NCHS) in 2015, it is estimated that 15% of children between the ages of 3 and 17 years are affected by NDs [20].
In a previous systematic review by our research team [3], we found that the global prevalence rate of NDs fluctuates globally between 4.70% in Scotland [8], 55.5% in Norway [9], and 88.50% in Japan [10].
These variations depended on methodological aspects, such as estimation procedures and sociocontextual phenomena. The criteria used by the different studies varied, and the processes used to measure the indicators were often not explicitly stated. In addition, it should be considered that the validity and reliability of the assessment instruments used were not explicitly mentioned and, in many cases, were nonexistent. In our study, we used a diagnostic approach to consider the problems of measurement and validity with respect to the data collection techniques used not only in our study but also in general.
There was also little direct evaluation and, consequently, little diagnostic certainty regarding the clinical populations in these studies. Furthermore, the studies often did not consider the complexity and comorbidities of the disorders; instead, symptoms or risks tended to be analyzed individually. Secondary sources are important as complementary resources for diagnosis, but prevalence studies with direct sources are lacking. Among the few studies where symptoms were directly assessed, in the study of Catalonia [7] and Norway [9], clinical diagnostic measures and questionnaires were used to assess symptoms and were completed by teachers. The Japan study [10] used surveys and questionnaires completed by parents and teachers. Most prevalence studies used indirect estimates such as health database records, which are likely to be less accurate. For example, not explicitly stating the overlap of comorbidities and results could be misleading and lead to overestimating the risk. However, we believe that this is a complex aspect from an empirical point of view. In our study, we have used the added criterion of diagnostic risk in the tests administered; specifically, we report the number of diagnoses for each participant.
NDs are usually underdiagnosed [21]. Therefore, children who have not been diagnosed are more likely to suffer from emotional and behavioral problems, low self-esteem, lower-than-expected academic performance, difficulties in social relationships, unemployment, delinquent behavior and functional impairment [22, 23]. The implementation of early detection and early intervention programs is essential [24].
NDs usually present as homotypic comorbidities, and it is rare that they occur in isolation. Despite this, there is a large body of literature on specific disorders, and these disorders have rarely been evaluated as a whole.
Multimorbidity among individuals with NDs is the norm, as determined in Japan [10], low-resource countries [6], Scotland [8], Spain [11], and Norway [9]. The prevalence of NDs seems to remain stable over time in different cultures, ages, ethnic groups [25] socioeconomic strata, types of communities (rural or urban), and religions [26]. Gender differences in NDs are consistent, with males being most affected by general psychiatric psychopathology, as reflected in studies in Scotland [8] and Denmark [27].
Males are more affected by NDs; 66.3% of the children included in a cross-sectional study in Norway [9] were male, and in a sequential cross-sectional study in Japan [28], a male:female ratio of 2.2:1 was reported. With regard to ADHD, male:female ratios of 4:1 and 2:1 were determined in a systematic review and meta-analysis in Spain [29, 30], generally corresponding with the reported ratios (3-2:1) in the systematic reviews by Sayal et al. (2018) and Faraone et al. (2021). Finally, a male:female ratio of 4.5:1 was reported in children with ASD in a retrospective analytical cohort study [31].
Considering the prevalence variations found in the different studies analyzed worldwide, we considered it necessary to carry out more studies in nonclinical samples and with direct evaluations that better reflect the reality of the population. In Catalonia [7] and the USA [32], a study was conducted with a school sample; in Galicia [11], Catalonia [31], Norway [9] and Brazil [33], a study was conducted with a clinical sample of children receiving specialized mental health services.
In countries with low socioeconomic resources [6], such as China [34] and Japan [10], a sample of the general population (rural and urban) was obtained. For this reason, we decided to conduct this study in a primary care sample, which we thought would more accurately reflect prevalence risk approximations than clinical samples. The age of 6 years was selected to insist on early detection and to demonstrate the possibility of providing an intervention through secondary prevention. These interventions can be performed at early ages when neuronal plasticity is still present, even if only the most severe forms of learning problems are usually detected at 6 years of age. Due to the heterogeneity of these disorders, the choice of 6 years of age limits our ability to diagnose the most severe cases of ASD or ID that would be detected before 3 years of age. Even so, we have observed an underdiagnosis of the more subtle forms of ASD in children with higher IQs. This is the first study in a school-age population where an exhaustive and direct assessment was carried out by professionals trained in neurodevelopment.
This is the first study of its type that has been carried out in a nonclinical population on the island of Menorca and with direct observations of the participants.
The general objective of the study was to obtain evidence on the prevalence and comorbidity of NDs to establish the fundamental elements for good health planning based on secondary prevention and early detection of subtle symptoms, which may go unnoticed if not explored in primary care services.
The specific objectives were as follows:
-
a)
to estimate the prevalence of NDs on the island of Menorca based on standardized tests and interviews with parents.
-
b)
to establish the territorial differentiation of each disorder, considering its prevalence.
-
c)
to determine the comorbidity of these disorders on the island.
-
d)
to predict the presence of a comorbidity based on the NDs analyzed and the sociodemographic characteristics analyzed and considered.
Finally, this study measured the risks of presenting any ND according to the DSM-5 (that is, ADHD, ASD, SLDs, MDs and CDs) and their possible comorbidities. ID, learning disabilities with difficulties in writing and mathematics and motor coordination problems were not assessed due to time and cost limitations.
There are numerous studies in the literature on the possible association between the environment and the development of NDs. Multiple and varied environmental factors have been studied (biological, social and economic factors). We could say that they comprise a broad spectrum of environmental pollutants [35, 36], pre/perinatal risk factors [37, 38] unhealthy lifestyle habits and disadvantaged environments (social exclusion, poverty, low purchasing power) [39, 40]. All these factors could act at the epigenetic level, modifying gene expression and favoring the development of a given condition.